60 Degrees Pharmaceuticals (SXTP) Income towards Parent Company (2022 - 2025)
Historic Income towards Parent Company for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to -$2.3 million.
- 60 Degrees Pharmaceuticals' Income towards Parent Company fell 724.55% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 31.73%. This contributed to the annual value of -$8.0 million for FY2024, which is 10860.2% down from last year.
- Per 60 Degrees Pharmaceuticals' latest filing, its Income towards Parent Company stood at -$2.3 million for Q3 2025, which was down 724.55% from -$1.7 million recorded in Q2 2025.
- 60 Degrees Pharmaceuticals' 5-year Income towards Parent Company high stood at $4.2 million for Q3 2023, and its period low was -$4.2 million during Q2 2024.
- Over the past 4 years, 60 Degrees Pharmaceuticals' median Income towards Parent Company value was -$2.0 million (recorded in 2023), while the average stood at -$1.6 million.
- Per our database at Business Quant, 60 Degrees Pharmaceuticals' Income towards Parent Company surged by 38769.81% in 2023 and then crashed by 53863.71% in 2025.
- 60 Degrees Pharmaceuticals' Income towards Parent Company (Quarter) stood at -$1.7 million in 2022, then fell by 22.55% to -$2.0 million in 2023, then decreased by 0.13% to -$2.0 million in 2024, then decreased by 13.09% to -$2.3 million in 2025.
- Its Income towards Parent Company was -$2.3 million in Q3 2025, compared to -$1.7 million in Q2 2025 and -$1.9 million in Q1 2025.